Definitive Healthcare Corp. (DH) Reports In-Line Q4 EPS

Go back to Definitive Healthcare Corp. (DH) Reports In-Line Q4 EPS

Canaccord Genuity Upgrades Definitive Healthcare Corp (DH) to Buy

February 24, 2022 7:29 AM EST

Canaccord Genuity analyst David Hynes Jr. upgraded Definitive Healthcare Corp (NASDAQ: DH) from Hold to Buy with a price target of $28.00 (from $46.00).

The analyst commented, "All in all, this was a strong print and we feel pretty good about the setup for... More

Definitive Healthcare Corp (DH) PT Lowered to $35 at Stifel

February 24, 2022 7:17 AM EST

Stifel analyst David Grossman lowered the price target on Definitive Healthcare Corp (NASDAQ: DH) to $35.00 (from $48.00) while maintaining a Buy rating.

The analyst commented, "DH reported a modest 4Q beat (+33% organic revenue growth) and, excluding a recent acquisition, guided 2022 revenue/EBITDA modestly above consensus.... More